Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AKYmed is a private Swiss biotechnology and health diagnostics company focused on fertility analysis, genetics, and cryopreservation solutions for human reproductive medicine, animal breeding, and conservation. Its core commercial offering is QualiSperm CASA, a patented computer-assisted sperm analysis platform used for objective assessment of sperm concentration, motility, morphology, and vitality. The company also provides cryopreservation and biobanking solutions, laboratory consumables, and genomics services. Through its Noah Genetics brand, AKYmed extends into animal artificial reproduction, breeding optimization, and preservation of genetic diversity for livestock, aquaculture, companion animals, and wildlife conservation. The business appears to be commercially active rather than a drug-development company, with revenues likely driven by diagnostic systems, services, and related consumables.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AKYmed.